The effects of flavonoids on cardiovascular health:

a review of human intervention trials and

implications for cerebrovascular function by Rees, Amy et al.
The effects of flavonoids on 
cardiovascular health: a review of human 
intervention trials and implications for 
cerebrovascular function 
Article 
Published Version 
Creative Commons: Attribution 4.0 (CC­BY) 
Rees, A., Dodd, G. F. and Spencer, J. P. E. (2018) The effects 
of flavonoids on cardiovascular health: a review of human 
intervention trials and implications for cerebrovascular 
function. Nutrients, 10 (12). 1852. ISSN 2072­6643 doi: 
https://doi.org/10.3390/nu10121852 Available at 
http://centaur.reading.ac.uk/80967/ 
It is advisable to refer to the publisher’s version if you intend to cite from the 
work.  See Guidance on citing .
To link to this article DOI: http://dx.doi.org/10.3390/nu10121852 
Publisher: MDPI 
All outputs in CentAUR are protected by Intellectual Property Rights law, 
including copyright law. Copyright and IPR is retained by the creators or other 
copyright holders. Terms and conditions for use of this material are defined in 
the End User Agreement . 
www.reading.ac.uk/centaur 
CentAUR 
Central Archive at the University of Reading 
Reading’s research outputs online
nutrients
Review
The Effects of Flavonoids on Cardiovascular Health:
A Review of Human Intervention Trials and
Implications for Cerebrovascular Function
Amy Rees, Georgina F. Dodd and Jeremy P. E. Spencer *
Department of Food and Nutritional Sciences, University of Reading, Whiteknights, Reading RG6 6AP, UK;
a.j.rees@pgr.reading.ac.uk (A.R.); g.dodd@reading.ac.uk (G.F.D.)
* Correspondence: j.p.e.spencer@reading.ac.uk; Tel.: +44-0118-378-8724
Received: 5 November 2018; Accepted: 21 November 2018; Published: 1 December 2018


Abstract: Research has suggested a number of beneficial effects arising from the consumption of
dietary flavonoids, found in foods such as cocoa, apples, tea, citrus fruits and berries on cardiovascular
risk factors such as high blood pressure and endothelial dysfunction. These effects are thought to have
a significant impact upon both vascular and cerebrovascular health, ultimately with the potential to
prevent cardiovascular and potentially neurodegenerative disease with a vascular component, for
example vascular dementia. This review explores the current evidence for the effects of flavonoid
supplementation on human endothelial function and both peripheral and cerebral blood flow (CBF).
Evidence presented includes their potential to reduce blood pressure in hypertensive individuals,
as well as increasing peripheral blood perfusion and promoting CBF in both healthy and at-risk
populations. However, there is great variation in the literature due to the heterogeneous nature of
the randomised controlled trials conducted. As such, there is a clear need for further research and
understanding within this area in order to maximise potential health benefits.
Keywords: flavonoid; cocoa; blood pressure; flow-mediated dilation; cerebral blood flow; cardiovascular
disease; cerebrovascular function
1. Cardiovascular Health and Flavonoids
Cardiovascular disease (CVD) is one of the main causes of death worldwide, yet it is largely
preventable [1]. Although there are now treatments available, focus should be on prevention of disease
through reduction of risk factors which could be achieved by encouraging healthy lifestyle choices.
A further implication of CVD is its link with neurodegenerative diseases of a vascular aetiology such as
vascular dementia [2,3]. Dementia is a growing concern worldwide as people are living longer, and
a condition for which we currently do not have any effective treatments. Therefore, prevention of
CVD and its risk factors is not only important for vascular health but also cerebrovascular health.
The impact of diet on such diseases is of particular interest with emerging research suggesting that
dietary flavonoids may have cardio- and neuro-protective effects [4–6], mediated by their interactions
with the vascular system [7–10]. However, to date, the precise mechanisms by which their effects are
mediated in vivo and what doses are required to induce such effects remain unclear.
Flavonoids are naturally occurring compounds found in a variety of fruit, vegetables, and
plant-based food products and represent the second largest group of polyphenols present in the
human diet. Flavonoids can be divided into several subclasses, based upon variations in the structure,
with the basic structure allowing for a large number of different substitutions in the A, B, and C
rings. Subclasses include flavonols, flavanones, anthocyanins, flavones, isoflavones, and the most
common subclass, flavanols. Flavanols exist in both the monomer form as catechins and the polymer
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form as proanthocyanidins, and are found predominantly in cocoa, apples, and tea [11]. Only a small
proportion of flavonoids ingested are absorbed intact, and the rate and extent to which they are
absorbed varies greatly on a number of factors such as the structure of the molecule, the matrix in
which it is bound and interactions with other components, as well as inter-individual differences such
as age, sex, and composition of the colonic microbiota [12]. Once ingested, flavonoids pass through
the stomach and into the small intestine where phase I metabolism occurs. Following absorption in
the epithelial cells of the small intestine, flavonoids undergo phase II metabolism to form conjugated
metabolites which enter the circulation via the portal vein [13]. However, only an estimated 5–10% of
total polyphenol intake is absorbed in the small intestine [14], with the remaining larger flavonoids
continuing on to the large intestine where the colonic microflora are able to degrade them into
low-molecular-weight metabolites which can be absorbed. Once in the bloodstream, metabolites are
transported around the body whereby they can act on the relevant tissues or are transported to the
liver for further metabolism before ultimately being excreted [13]. The large variation in bioavailability
of flavonoids can make it more difficult to study the effects they have within the body and can lead to
discrepancies in the literature.
Vascular function has been shown to be linked with cognition and brain function, with increased
cardiovascular health being associated with greater cognitive performance [15–17]. Furthermore, many
of the risk factors associated with cardiovascular health are also risk factors for cerebrovascular health,
such as hypertension, hypercholesterolemia, and diabetes, with CVD itself having been identified as a
risk factor for vascular dementia, caused by a reduction in blood flow to the brain [18,19]. Therefore,
it is important to understand the effect flavonoids have upon the vascular system in order to fully
understand the effect that they are also having on the brain (Figure 1).
Nutrients 2018, 10, x FOR PEER REVIEW  2 of 18 
 
Subclasses include flavonols, flavanones, anthocyanins, flavones, isoflavones, and the most common 
subclass, flavanols. Flavanols exist in both the monomer form as catechins and the polymer form as 
proanthocyanidins, and are found predominantly in cocoa, apples, and tea [11]. Only a small 
proportion of flavonoids ingested are absorbed intact, and the rate and extent to which they are 
absorbed varies greatly on a number of factors such as the structure of the molecule, the matrix in 
which it is bound and interactions with other components, as well as inter-individual differences 
such as age, sex, and composition of the colonic microbiota [12]. Once ingested, flavonoids pass 
through the stomach and into the small intestine where phase I metabolism occurs. Following 
absorption in the epithelial cells of the small intestine, flavonoids undergo phase II etabolism to 
form conjugated metabolite  which enter the circulatio  via the portal vein [13]. However, only an 
estimated 5–10% of total polyphenol intake is absorbed n the small intestine [14], with the remaining 
larger flavonoids continuing on to the large i testine wh re the olonic microflora are able to degrade 
them into low-molecular-weight metabolites which can b  absorbed. Once in the blo dstream, 
metabolites are transported around the body whereby they can act on the releva t tissues or are 
transported to the liver for further metabolism before ultimately being excreted [13]. The large 
variation in bioavailability of flavonoids can make it more difficult to study the effects they have 
within the body and can lead to discrepancies in the literature. 
Vascular function has been shown to be linked with cognition and brain function, with increased 
cardiovascular health being associated with greater cognitive performance [15–17]. Furthermore, 
many of the risk factors associated with cardiovascular health are also risk factors for cerebrovascular 
health, such as hypertension, hypercholesterolemia, and diabetes, with CVD itself having been 
identified as a risk factor for vascular dementia, caused by a reduction in blood flow to the brain 
[18,19]. Therefore, it is important to understand the effect flavonoids have upon the vascular system 
in order to fully understand the effect that they are also having on the brain (Figure 1). 
 
Figure 1. The effects of flavonoids on vascular and cerebrovascular function and implications for 
health. 
2. Epidemiological Evidence 
Recent epidemiological studies have suggested a positive association between diets high in 
flavonoid-rich foods and cardiovascular health [20–25]. An 18% reduction in the risk of fatal CVD in 
those with total flavonoid intakes in the top quintile (≥359.7 mg/day) compared with those in the 
bottom quintile (<121.5 mg/day) has been demonstrated and it has been suggested, due to the non-
linear nature of many of the associations observed, that even a relatively low habitual intake of 
flavonoid-rich foods may be beneficial in reducing the risk of fatal CVD [20]. An association between 
reduced risk of death due to CVD and dietary intake of flavanones, anthocyanidins and certain 
flavonoid-rich foods such as apples, red wine, grapefruit and chocolate was also found [21]. There 
have been a number of prospective studies which have highlighted in particular the association 
between higher chocolate, cocoa, or epicatechin intake and a lower risk of CVD mortality and future 
cardiovascular events [26–28]. Despite the majority of these studies suggesting a greater habitual 
intake of flavonoid-rich foods is associated with a lower risk of CVD, they cannot prove cause and 
effect due to the uncontrollable nature of observational studies. Methods of dietary assessment 
employed are not reliable, especially with huge variability in the flavonoid content of foods due to 
differences in growing and processing conditions, along with many other variables which cannot be 
Figure 1. The effects of flavonoids on vascular and cerebrovascular function and implications f r health.
2. Epidemiological Evidence
Recent epidemiological studies have suggested a positive association between diets high in
flavonoid-rich foods and cardiovascular health [20–25]. An 18% reduc in th risk of fatal CVD
in those with total flavonoid intakes in t top quintile (≥359.7 mg/day) compared with those in
the bottom quintile (<121.5 mg/day) has been demonstrated and it has been suggested, due to the
non-linear nature of many of the associations observed, that even a relatively low habitual intake of
flavonoid-rich foods may be beneficial in reducing the risk of fatal CVD [20]. An association between
reduced risk of death due to CVD and dietary intake of flavanones, anthocyanidins and certain
flavonoid-rich foods such as apples, red wine, grapefruit and chocolate was also found [21]. There have
been a number of prospective studies which have highlighted in particular the association between
higher chocolate, cocoa, or epicatechin intake and a lower risk of CVD mortality and future
cardiovascular events [26–28]. Despite the majority of these studies suggesting a greater habitual intake
of flavonoid-rich foods is associated with a lower risk of CVD, they cannot prove cause and effect due
to the uncontrollable nature of observational studies. Methods of dietary assessment employed are not
reliable, especially with huge variability in the flavonoid content of foods due to differences in growing
and processing conditions, along with many other variables which cannot be controlled. These studies
provide a good starting point for further research, but carrying out clinical trials is the only way to
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fully understand the effects flavonoids can have in the human body. Therefore, this review will explore
the current clinical evidence from human intervention randomised controlled trials for the effects of
flavonoid-rich foods, with a particular emphasis on cocoa, on vascular and cerebrovascular health.
3. Impact of Flavonoid Consumption on Blood Pressure
Blood pressure is an important predictor of cardiovascular health, with a lower blood pressure
being linked to better vascular health [29,30]. On a population level, a reduction in systolic blood
pressure of only 2 mmHg may result in a 10% lower stroke mortality and 7% lower mortality from
ischaemic heart disease and other vascular causes [31]. As such, the impact of flavonoid-rich food
consumption, cocoa in particular, on blood pressure has been studied fairly extensively. A reduction
of 4.4 mmHg and 3.9 mmHg in systolic and diastolic blood pressure respectively, was demonstrated
following consumption of a cocoa flavanol drink containing 900 mg total flavanols per day for 1 month
compared with a control [32]. Similarly, another trial observed a reduction in blood pressure (systolic:
−4.8 mmHg; diastolic: −3 mmHg) following consumption of 10 g cocoa containing various doses of
flavonoids up to 800 mg (0, 80, 200, 500 and 800 mg flavonoids) over the period of a week in healthy
adults [33]. A study investigating the effects of a cocoa flavanol drink containing 450 mg total flavanols
in healthy younger and older males found a significant decrease in systolic blood pressure in the older
group following acute consumption and daily intake over 2 weeks compared to baseline, but not
in the younger group, although the latter had reductions in diastolic blood pressure over an acute
timeframe [34]. At baseline, blood pressure was significantly greater in the older group suggesting that
either the younger group were too healthy for any effects to be seen or that flavonoids have a greater
effect in at-risk populations, whose vascular health is not at its optimum, and therefore, may benefit
most. Similar studies in at-risk populations, such as those with cardiovascular risk factors, have also
found positive effects. Flavanol-rich dark chocolate (821 mg flavanols) led to a reduction in blood
pressure (systolic: −3.2 mmHg; diastolic: −1.4 mmHg) 2 h post consumption in overweight adults [35].
The same study also found a reduction in blood pressure with a sugar free cocoa drink (805 mg
flavanols), however, there was no difference between the sugared cocoa drink (605 mg flavanols)
and the control, demonstrating that the beneficial effect of flavonoid-rich cocoa can be negated by
the detrimental effect of sugar in the diet. Observations such as these can help us to understand the
best form in which to administer cocoa flavanols in order to maximise the health benefits. Significant
reductions of 5.3 mmHg and 3 mmHg in systolic and diastolic blood pressure respectively, were
observed in subjects with mild, untreated hypertension following cocoa consumption over the course
of six weeks, but only in the highest dose administered of 1052 mg cocoa flavanols per day [36].
In contrast to this, a similar study showed significant reductions in systolic (−2.9 mmHg) and diastolic
(−1.9 mmHg) blood pressure following a much lower daily intake of only 30 mg cocoa flavanols
per days for 18 weeks in mildly hypertensive patients, perhaps due to the longer supplementation
period [37]. The authors also stated that the magnitude of reduction in blood pressure was greater in
those with higher blood pressure at baseline, again supporting the idea that the benefit of flavonoid
supplementation is greater in those with impaired vascular function. Significant reductions in blood
pressure were also found in elderly individuals with [38] and without [39] mild cognitive impairment
when consuming 520 mg or 993 mg of cocoa flavanols per day compared with a low dose of 48 mg.
However, there are a number of studies which have found no effect of cocoa flavanol intake on blood
pressure in healthy volunteers, possibly due to the dosage being too low to elicit effects [40–42], the
time frame for supplementation being too short [43], the use of pure epicatechin rather than a whole
food [44] or because effects are more likely to be seen in at-risk populations as mentioned previously.
The effects of a number of other flavonoid-rich foods on blood pressure have also been
investigated, although to a lesser extent than cocoa. Consumption of flavanol-rich apple, containing
180 mg (-)-epicatechin, resulted in a reduction in systolic blood pressure of 3.3 mmHg in healthy
adults [45]. On the other hand, no significant effect was found following consumption of apple
containing 48 mg epicatechin compared to a low-flavanol apple [46]. This may be due to the flavanol
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content being quite low, comparable to the levels used in control products in other studies [38,39],
although the total polyphenol content was greater at 306 mg/day. Black tea, also rich in flavanols,
particularly catechins, has been found to reduce both systolic (−2.6 mmHg) and diastolic (−2.2 mmHg)
blood pressure following daily consumption for 1 week in healthy males [47]. Chronic consumption
of three cups per day (429 mg total polyphenols) for six months also reduced blood pressure to a
similar extent in subjects with normal or slightly raised blood pressure [48]. Further reductions in
blood pressure (systolic: −3.2 mmHg; diastolic: −2.6 mmHg) were observed in hypertensive subjects
following consumption of black tea containing 258 mg flavonoids per day for a week, as well as the
ability of acute consumption to prevent an increase in blood pressure following a high fat load [49].
High fat meals have been found to increase postprandial blood pressure [50], and as much of the
day is spent in the postprandial state, relieving some of this stress on the vascular system could help
to improve overall vascular health. However, a similar study found an increase in blood pressure
following black tea consumption which was counteracted by consuming a meal alongside the tea [51].
Further research is required in order to understand these conflicting studies, but in general, black tea
appears to have a positive effect by reducing blood pressure in both healthy and hypertensive subjects.
The effects of anthocyanin-rich berries and flavanone-rich citrus fruitson blood pressure have not
been so convincing or as promising. A significant reduction in systolic blood pressure (−6 mmHg)
was observed in individuals with metabolic syndrome consuming polyphenol-rich grape powder
for 30 days compared with a control [52]. However, no significant effects were found following
consumption of blueberry juice [53], cranberry juice in healthy subjects [54] or subjects with coronary
artery disease (CAD) [55], and elderberry anthocyanins in postmenopausal women [56]. With respect
to flavanone-rich foods, orange juice was shown to significantly reduce diastolic blood pressure in
overweight males [57], yet no effects were found following consumption of orange juice in healthy
males [58], or grapefruit juice in healthy, postmenopausal women over a six month period [59]. Perhaps
the effects of flavanones are lesser, and therefore, only visible in those at risk of CVD, explaining the
reduction seen in blood pressure in overweight subjects but not in healthy subjects.
It is evident from these studies that flavanol-rich foods such as cocoa and tea, are able to lower
blood pressure in healthy as well as at-risk populations, such as those with hypertension and impaired
cardiovascular function. It is likely that improvements in endothelial function are responsible for
reductions observed, as discussed in greater detail elsewhere [60]; however, flavonoids may also be
able to directly affect blood pressure, for example, by inhibiting angiotensin-converting-enzyme (ACE)
activity [61]. Studies which observed no change in blood pressure perhaps used too low a dosage
of flavonoids, or too short a supplementation period, indicating that longer term supplementation
may be required in order to elicit significant effects. Overall, current evidence demonstrates a positive
effect of flavanols on blood pressure, but further research is required in order to elucidate the optimal
dose and time frame in which flavanols might reliably reduce blood pressure. On the other hand, the
evidence is not so clear cut with respect to anthocyanins and flavanones, perhaps due to a lack of
studies. It is also possible that these subclasses of flavonoids are not able to modify blood pressure,
or the effects are smaller, and therefore, only apparent in those with compromised vascular function.
However, this theory would need to be substantiated with further research and evidence. See Table 1
for a summary of studies assessing the impact of flavonoids on blood pressure.
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Table 1. Summary of studies investigating the effect of flavonoids on blood pressure.
Author Flavonoid Source and Dose Duration Sample Effects
Sansone
et al. (2015) [32]
Cocoa
900 mg flavanols 1 month Healthy subjects (n = 100)
−4.4 mmHg SBP,
−3.9 mmHg DBP
Grassi
et al. (2015) [33]
Cocoa
80, 200, 500, 800 mg flavonoids 1 week Healthy subjects (n = 20)
−4.8 mmHg SBP,
−3 mmHg DBP
Heiss
et al. (2015) [34]
Cocoa
450 mg flavanols twice/daily
Acute and
2 weeks
Healthy younger (aged <35 year, n = 22)
and older males (aged 50−80 year, n = 20)
−5 mmHg SBP (acute) and
−6 mmHg SBP (chronic) in older group
Faridi
et al. (2008) [35]
Dark chocolate
821 mg flavanols Acute Overweight subjects (n = 45)
−3.2 mmHg SBP,
−1.4 mmHg DBP
Cocoa
805 mg flavanols (sugar-free),
605 mg flavanols (sugared)
Acute Overweight subjects (n = 45)
−2.1 mmHg SBP,
−1.2 mmHg DBP;
no effect of sugared cocoa
Davison
et al. (2010) [36]
Cocoa
33, 372, 712, 1052 mg flavanols 6 weeks Mildly hypertensive subjects (n = 52)
−5.3 mmHg SBP,
−3 mmHg DBP at highest dose,
no other effects
Taubert
et al. (2007) [37]
Cocoa
30 mg total polyphenols 18 weeks Mildly hypertensive subjects (n = 44)
−2.9 mmHg SBP,
−1.9 mmHg DBP
Desideri
et al. (2012) [38]
Cocoa
48, 520, 993 mg flavanols 8 weeks Elderly subjects with MCI (n = 90)
−10 mmHg SBP,
−4.8 mmHg DBP
Mastroiacovo
et al. (2015) [39]
Cocoa
48, 520, 993 mg flavanols 8 weeks Elderly subjects (n = 90)
−7.8 mmHg SBP,
−4.8 mmHg DBP
Massee
et al. (2015) [40]
Cocoa
250 mg polyphenols
Acute and
4 weeks Healthy subjects (n = 40) No significant effect
Engler
et al. (2004) [41]
Cocoa
213 mg procyanidins,
48 mg epicatechin
2 weeks Healthy subjects (n = 22) No significant effect
Dower
et al. (2016) [42]
Dark chocolate
150 mg epicatechin, 100 mg pure
epicatechin with white chocolate
Acute Healthy males (n = 20) No significant effect
Fisher and Hollenberg
(2006) [43]
Cocoa
821 mg flavanols 4−6 days
Healthy younger (aged<50 year, n = 15),
and older subjects (>50 year, n = 19) No significant effect
Dower
et al. (2015) [44]
Pure epicatechin
100 mg 4 weeks Healthy subjects (n = 37) No significant effect
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Table 1. Cont.
Author Flavonoid Source and Dose Duration Sample Effects
Bondonno
et al. (2012) [45]
Apple
180 mg epicatechin,
184 mg quercetin
Acute Healthy subjects (n = 30) −3.3 mmHg SBP,no significant effect on DBP
Bondonno
et al. (2017) [46]
Apple
48 mg epicatechin,
306 mg total polyphenols
Acute and
4 weeks Subjects at risk of CVD (n = 30) No significant effect
Grassi
et al. (2009) [47]
Black tea
100, 200, 400, 800 mg flavonoids 1 week Healthy males (n = 19)
−2.6 mmHg SBP,
−2.2 mmHg DBP
Hodgson
et al. (2012) [48]
Black tea
429 mg total polyphenols 6 months
Healthy to mildly
hypertensive subjects (n = 95)
−2.7 mmHg SBP,
−2.3 mmHg DBP
Grassi
et al. (2015) [49]
Black tea
258 mg flavonoids 1 week Hypertensive subjects (n = 19)
−3.2 mmHg SBP,
−2.6 mmHg DBP
Barona
et al. (2012) [52]
Grape
35 mg anthocyanins,
267 mg total polyphenols
1 month Subjects with metabolic syndrome (n = 24) −6 mmHg SBP,no significant effect on DBP
Rodriguez-Mateos
et al. (2013) [53]
Blueberry
766, 1278, 1791 mg polyphenols Acute Healthy males (n = 10) No significant effect
Rodrigues-Mateos
et al. (2016) [54]
Cranberry
409, 787, 1238,
1534, 1910 mg total polyphenols
Acute Healthy males (n = 10) No significant effect
Dohadwala
et al. (2011) [55]
Cranberry
94 mg anthocyanins,
835 mg total polyphenols
4 weeks Subjects with CAD (n = 44) No significant effect
Curtis
et al. (2009) [56]
Elderberry
500 mg anthocyanins 12 weeks Postmenopausal women (n = 52) No significant effect
Morand
et al. (2011) [57]
Orange juice
292 mg hesperidin 4 weeks Overweight males (n = 24)
−5.5 mmHg DBP,
no significant effect on SBP
Rendeiro
et al. (2016) [58]
Orange juice
128, 272, 452 mg total flavonoids Acute Healthy males (n = 28) No significant effect
Habauzit
et al. (2015) [59]
Grapefruit
210 mg naringenin 6 months Postmenopausal women (n = 48) No significant effect
CAD: coronary artery disease, CVD: cardiovascular disease, DBP: diastolic blood pressure, MCI: mild cognitive impairment, SBP: systolic blood pressure.
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4. Impact of Flavonoid Consumption on Endothelial Function
There is an increasing body of evidence from randomised, controlled clinical trials suggesting
that flavonoids may be beneficial for the vascular system, particularly with regard to the prevention
of endothelial dysfunction [41,45,47,53]. Endothelial function can be described as arterial vasomotor
responses mediated by the release of vasodilatory and vasoconstricting chemicals from the
endothelium [62]. An imbalance in these endothelium-derived relaxing and contracting factors
results in endothelial dysfunction, most commonly characterised by the impaired release of the
vasodilator, nitric oxide (NO), predisposing the vasculature to vasoconstriction [63–65]. A reduction in
NO bioavailability may occur as a result of reduced production by endothelial nitric oxide synthase
(eNOS) or increased breakdown by reactive oxygen species [66]. Endothelial dysfunction, considered
to take place early on in the pathology of vascular disease, contributes to atherosclerotic plaque
formation and has been found to correlate with future cardiovascular events [64,67]. Endothelial
function (or dysfunction) can be measured non-invasively using a technique called flow-mediated
dilation (FMD), the current preferred method for assessing endothelial function [68]. Increases in
FMD, and therefore improvements in vascular function, have been demonstrated following the
consumption of a wide variety of flavonoid-rich foods and derived beverages, including cocoa,
blueberries, black tea, and apples [32,35,41,45,46,52,53,58,69]. Through measuring endothelial function,
FMD effectively reflects NO bioavailability in vivo, thus an improvement in FMD response following
flavonoid consumption would suggest an increase in the levels and activity of eNOS, a major source of
NO in the endothelium [3,70,71].
Flavanol-rich cocoa in particular has been studied for its potentially beneficial effect on endothelial
function with FMD response having been shown to improve, and therefore reduce cardiovascular risk,
in a number of human intervention studies following acute and chronic supplementation [32,35,43,72].
In a study looking at acute consumption of a single dose of dark chocolate (821 mg total flavanols) in
45 overweight subjects, an increase in FMD response of 4.3% was observed compared with the control
after 2 h [35]. Acute dark chocolate consumption, containing a lower dose of 395 mg total flavanols, was
found to increase FMD response by 2.4% compared with milk and white chocolate [73]. A significant
increase in FMD response was also found in 10 healthy volunteers following consumption of a single
cocoa beverage, containing 917 mg flavanols, up to 4 h post consumption [72]. A simultaneous increase
in nitroso species concentrations was observed up to 3 h post consumption, supporting the theory that
cocoa flavanols are able to improve FMD response through the activation of eNOS. Further to this,
subjects were given solutions containing 1 mg/kg and 2 mg/kg body weight pure epicatechin and
FMD was found to significantly increase with both doses, compared with baseline and the control, to a
similar level as that found with high flavanol cocoa [72]. This suggests that the beneficial effects of
cocoa on endothelial function are related, at least in part, to epicatechin content. A clear limitation of
this study was that it was carried out in only three subjects but as a proof-of-concept study it appears
promising. However, a similar study looking at pure epicatechin supplementation over a four week
period found no significant change in FMD and suggested that epicatechin was not responsible for the
observed vascular effects of cocoa [44]. Following on from this, acute consumption of dark chocolate
was found to significantly increase FMD compared to the control whereas pure epicatechin did not
produce a significant effect [42]. The lack of effects observed with pure epicatechin may be due to
the lower doses used in both studies as volunteers consumed only 100 mg (-)-epicatechin per day.
Epicatechin has been found to increase NO at doses of 200 mg [74] and so the dosage of 100 mg may
not have been high enough to elicit effects on endothelial function. Furthermore, in the latter study
pure epicatechin was consumed with white chocolate which contains more sugar and less theobromine
and magnesium than dark chocolate, all of which may have contributed to the lack of effect [42].
Other studies have considered the effects that may arise following longer-term supplementation
with cocoa flavanols. Flow-mediated dilation response increased following daily supplementation
with a high flavonoid (259 mg total flavonoids) chocolate compared with a control over two weeks,
with a mean change of 1.3% in the high flavonoid group [41]. Similar increases in FMD response
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of 1.2% were found following daily consumption of a cocoa drink containing 900 mg total flavanols
over the period of a month [32]. Whilst these do not appear to be large improvements in FMD, it
is a promising response, as a 1% increase in FMD has been associated with a 13% lower risk of
cardiovascular event at population level [75]. Flavanol-rich cocoa (821 mg) consumption was also
found to significantly increase FMD response over a five-day period in younger (<50 years) and older
(≥50 years) population groups; however, the effect observed was greater in the older population [43].
This corresponds with studies on blood pressure [34], suggesting that there may be a greater benefit of
flavanol supplementation in advancing age, when endothelial function is more likely to be impaired
and vascular health is not optimum. A study looking at the effects of apples, also rich in flavanols,
on endothelial function in healthy subjects demonstrated a greater FMD response and increased
levels of circulating nitroso species following flavonoid-rich apple (180 mg (-)-epicatechin and 184 mg
quercetin) consumption [45]. More recently, the beneficial effect of apples on endothelial function was
demonstrated in individuals at risk of CVD with a significant increase in FMD following both acute
(0.8%) and four weeks of chronic (0.5%) consumption of high flavonoid apples (48 mg epicatechin) [46].
Although this significant increase in FMD is not substantial, as discussed previously, even moderate
increases in FMD may have a significant effect on vascular health and the prevention of CVD. On the
other hand, daily consumption of apple polyphenol extract, containing 100 mg epicatechin, over a four
week period had no significant effect on FMD response in borderline hypertensives compared with the
control [76]. Flow-mediated dilation response was measured one and a half hours post consumption
of the intervention; as other studies have found improvements in endothelial function at 2 h, FMD
may have been measured too early to observe a significant effect. In summary, current research
does not lead to a clear conclusion on the acute effects of FMD and flavanol supplementation due to
conflicting evidence. Acute studies, supplemented with higher levels of cocoa flavanols, observed
positive effects [35,72], whilst those supplementing with lower levels did not [44]. The chronic effects
are more promising with little conflicting evidence, even when considering the dosage administered.
It may therefore follow that a larger dosage is required to elicit an immediate effect in acute studies,
perhaps due to the differing rates of absorption of flavonoids following ingestion, or due to immediate
effects not being as powerful as those which have arisen due to chronic supplementation; however,
further research would be required to substantiate these theories. Overall, the evidence from existing
studies would imply flavanols can improve blood flow in the periphery, through increasing levels of
NO available in the endothelium, providing an efficacious dose is administered.
Research into the effects of other flavonoid-rich foods on endothelial function has also revealed
promising effects. Black tea was found to improve FMD response in a dose-dependent manner
with as little as 100 mg of flavonoids per day, equivalent to less than one cup of tea, being found
to increase FMD compared with the control [47]. A significant improvement in FMD response was
also observed following both acute and one week daily consumption of black tea compared with hot
water [69], whilst acute consumption of both green and black tea was found to significantly improve
FMD response by 5% and 4.4% respectively, compared with a control in healthy adults [77]. These
studies demonstrate the beneficial effects which could be achieved with the incorporation of a realistic
dose of flavonoid-rich black or green tea into the diet. Black tea consumption has also been found to
improve fasted FMD response in patients with CAD [78] and in hypertensives [79]. Black tea was also
able to counteract the impairment to FMD response with a high-fat challenge in hypertensives [79].
High-fat meals have been found to impair endothelial function postprandially [80] and so the ability of
flavonoids to prevent this demonstrates the beneficial effects they are able to exert when the vascular
system is compromised or put under stress.
Anthocyanin-rich foods such as grapes, blueberries, and cranberries, and their derivatives, have
also been studied but with mixed outcomes. No effects of wine grape or grape seed (800 mg total
polyphenols) on FMD were observed over a three-week period in healthy males [81]; however,
significant increases in FMD were found following consumption of a grape polyphenol for 30 days
in men with metabolic syndrome [52], and consumption of purple grape juice for 14 days in patients
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with CAD [82]. The conflicting results of these studies suggests that the effects of some flavonoid-rich
foods may be more significant in patients and those at risk of developing disease rather than healthy
individuals. Blueberries have been shown to significantly increase FMD response in healthy adults with
peaks at 1–2 and 6 h post ingestion of polyphenol-rich blueberry drinks [53]. The study demonstrated
a linear increase in FMD response, plateauing at a dose of 766 mg total polyphenols. This suggests that
there is an optimum dose and that too great an intake may even negate some of the positive effects.
A reduction in neutrophil NADPH oxidase activity coincided with increases in FMD, suggesting this
as a potential mechanism of action whereby superoxide generation is reduced and NO availability is
greater [53]. Furthermore, the beneficial vascular effects of cranberries have been demonstrated, with
dose-dependent improvements in FMD response following consumption of cranberry juice, peaking at
4 h and with a maximal effect with juice containing 1238 mg total polyphenols [54]. Further studies into
the dose-dependent effects of various flavonoids would be extremely useful when looking to maximise
health benefits. However, there were no effects on FMD response observed following consumption of
cranberry juice (835 mg total polyphenols) for four weeks in patients with CAD [55]. These two studies
used similar doses of cranberry polyphenols; however, the latter measured FMD response in fasted
subjects. This suggests that whilst anthocyanins may be able to exert effects whilst they remain in the
blood stream, they may be unable to wield any long standing effects. If this is indeed the case, this
would be important when considering how best to utilise anthocyanins for the prevention of disease,
as perhaps intake should be spread across the day in order to have the optimum effect.
Another subclass of flavonoids, flavanones, found commonly in citrus fruits, have also been
of interest. Flavanone-rich orange juice was able to prevent postprandial endothelial function in
healthy males with FMD response returning to baseline levels and plasma nitrite levels remaining
constant compared with a control drink [58]. This study demonstrates a positive effect by ameliorating
postprandial endothelial dysfunction following a high-fat meal, again demonstrating the potential of
flavonoids to have greater effects in situations in which vascular health is compromised. The flavanone
hesperidin has also been found to improve endothelial function with a daily 500 mg dose for three
weeks, improving FMD response by 2.5% in individuals with metabolic syndrome [83]. On the
other hand, FMD response remained unchanged in postmenopausal women following a six month
supplementation period with grapefruit juice [59]. As discussed previously, this may be due to
endothelial function being measured in fasted subjects. Hesperidin was able to elicit effects in fasted
subjects [83], but perhaps the improvement in FMD observed was due to the population of the study
being at risk, or the pure flavanone being able to elicit a stronger effect. Either way these conflicting
studies demonstrate the need for further research in this area.
It is evident that flavonoids have the potential to improve FMD response, and therefore,
endothelial dysfunction in both healthy and at-risk populations, as well as when the vascular system is
under stress, for example, following a high fat or sugar meal. There is a greater body of evidence with
respect to the effects of anthocyanins and flavanones on FMD response, unlike with blood pressure,
and current research suggests that all subclasses of flavonoids may be able to enhance endothelial
function. However, it is clear that a greater understanding is required of how flavonoids work in vivo
and how to incorporate them into the diet in order to fully capitalise on the potential benefits they
could have on endothelial function and the vascular system, and their potential to reduce the risk of
CVD. See Table 2 for a summary of studies assessing the impact of flavonoids on endothelial function.
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Table 2. Summary of studies investigating the effect of flavonoids on endothelial function.
Study Flavonoid Source and Dose Duration Sample Effects
Faridi et al.
(2008) [35]
Dark chocolate
821 mg flavanols Acute Overweight subjects (n = 45) 4.3% increase in FMD
Marsh et al.
(2017) [73]
Chocolate
395 mg (dark),
200 mg (milk) total polyphenols
Acute Postmenopausal women (n = 12)
2.4% increase in FMD following
dark chocolate, no significant
effect of milk chocolate
Schroeter et al.
(2006) [72]
Cocoa
917 mg flavanols Acute Healthy subjects (n = 10) Increase in FMD
Pure epicatechin
1 mg/kg, 2 mg/kg body weight Acute Healthy subjects (n = 3) Increase in FMD
Dower at al.
(2015) [44]
Pure epicatechin
100 mg 4 weeks Healthy subjects (n = 37) No significant effect
Dower et al.
(2016) [42]
Dark chocolate
150 mg epicatechin, 100 mg pure
epicatechin with white chocolate
Acute Healthy males (n = 20) 0.96% increase in FMD, nosignificant effect of pure epicatechin
Engler et al.
(2004) [41]
Chocolate
259 mg total flavonoids 2 weeks Healthy subjects (n = 22) 1.3% increase in FMD
Sansone et al.
(2015) [32]
Cocoa
900 mg flavanols 1 month Healthy subjects (n = 100) 1.2% increase in FMD
Fisher and
Hollenberg
(2006) [43]
Cocoa
821 mg flavanols 4–6 days
Healthy younger (aged <50 year, n = 15),
and older subjects (>50 year, n = 19)
3.5% (younger) and 4.5%
increase in FMD (older)
Bondonno et al.
(2012) [45]
Apples
180 mg epicatechin,
184 mg quercetin
Acute Healthy subjects (n = 30) 1.1% increase in FMD
Bondonno et al.
(2017) [46]
Apples
48 mg epicatechin,
306 mg total polyphenols
Acute and
4 weeks Subjects at risk of CVD (n = 30)
0.8% (acute) and 0.5%
(chronic) increase in FMD
Saarenhovi et al.
(2017) [76]
Apple
100 mg epicatechin
Acute and
4 weeks
Borderline hypertensive
subjects (n = 60) No significant effect
Grassi et al.
(2009) [47]
Black tea
100, 200, 400, 800 mg flavonoids 1 week Healthy males (n = 19) 2.5% increase in FMD
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Table 2. Cont.
Study Flavonoid Source and Dose Duration Sample Effects
Schreuder et al.
(2014) [69]
Black tea
1800 mg total polyphenols
Acute and
1 week Healthy subjects (n = 20) 1.4% increase in FMD
Jochmann et al.
(2008) [77]
Black and green tea
560 mg (black),
1012 mg (green) total catechins
Acute Postmenopausal women (n = 24) 4.4% (black) and5% (green) increase in FMD
Duffy et al.
(2001) [77]
Black tea
964 mg total flavonoids
Acute and
4 weeks Subjects with CAD (n = 50)
4.8% increase in FMD
(acute-on-chronic)
Grassi et al.
(2016) [79]
Black tea
150 mg polyphenols twice/day
Acute and
8 days Hypertensive subjects (n = 19)
1% (acute) and 1.8%
(chronic) increase in FMD
van Mierlo et al.
(2010) [81]
Wine and grape seed
800 mg total polyphenols 3 weeks Healthy males (n = 35) No significant effect
Barona et al.
(2012) [52]
Grape
35 mg anthocyanins,
267 mg total polyphenols
1 month Subjects with metabolicsyndrome (n = 24) 1.7% increase in FMD
Stein et al.
(1999) [82] Grape 14 days Subjects with CAD (n = 15) 4.2% increase in FMD
Rodriguez-Mateos
et al. (2013) [53]
Blueberry
766, 1278, 1791 mg polyphenols Acute Healthy males (n = 10) 2.4% increase in FMD
Rodriguez-Mateos
et al. (2016) [54]
Cranberry
409, 787, 1238, 1534,
1910 mg total polyphenols
Acute Healthy males (n = 10) 2.6% increase in FMD
Dohadwala et al.
(2011) [55]
Cranberry
835 mg total polyphenols 4 weeks Subjects with CAD (n = 44) No significant effect
Rendeiro et al.
(2016) [58]
Orange
128, 272, 452 mg total flavonoids Acute Healthy males (n = 28)
Recovery in % FMD to baseline
levels following a high fat meal
Rizza et al.
(2011) [83]
Hesperidin
500 mg hesperidin 3 weeks
Subjects with metabolic
syndrome (n = 24) 2.5% increase in FMD
Habauzit et al.
(2015) [59]
Grapefruit
210 mg naringenin 6 months Postmenopausal women (n = 48) No significant effect
Absolute change in FMD (flow-mediated dilation) response provided where available.
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5. Impact of Flavonoid Consumption on Cerebral Blood Flow
Whilst there is now a fairly large body of evidence for the effect of flavonoids on vascular
health and blood flow in the periphery, effects of flavonoids on cerebrovascular health and blood
flow in the brain is an emerging area of research. Evidence suggests that flavonoids may have a
neuroprotective effect, with the potential to slow the cognitive decline typically associated with
ageing [7]. The mechanisms behind these neuroprotective effects are thought to be similar to those
acting in the periphery, for example, greater bioavailability of NO, and thus optimal blood flow [84,85].
Increased levels of NO in the cerebrovascular system may improve blood flow throughout the brain,
thus inducing neurogenesis in the dentate gyrus of the hippocampus, promoting nerve cell growth
and leading to changes in neuronal morphology [86,87]. It is possible that flavonoids, if capable of
entering the brain [88–90], are also able to improve synaptic plasticity and communication whilst
preventing neuroinflammation, ultimately demonstrating an overall neuroprotective effect [13,91].
These combined effects are thought to result in the prevention, or perhaps even the slowing down of
progression, of neurodegenerative diseases such as vascular dementia [6].
The flow of blood to and from the brain, known as cerebral blood flow (CBF), provides the
brain with a constant supply of glucose and oxygen, and therefore, adequate CBF is essential
for the normal functioning of the brain; an insufficient supply of energy will ultimately result in
neuronal damage [92,93]. Cerebral hypoperfusion occurs naturally as part of the ageing process
but cardiovascular risk factors may promote further reductions in CBF, demonstrated particularly
in areas of the brain such as the hippocampus and anterior cingulate cortex thought to precede
neurodegenerative disorders such as vascular dementia and Alzheimer’s disease [94–97]. A number
of studies have now demonstrated a beneficial effect of flavonoid-rich foods on CBF and although the
precise mechanisms are not yet known, it is thought that this can occur through similar mechanisms to
those acting when peripheral blood flow is increased [98–100].
There is a growing body of evidence for the effects of flavonoid-rich cocoa on CBF and cocoa has
been found to improve cognitive function, perhaps through improving blood flow around the body
and increasing the flow of blood to the brain [98,101]. An increase in CBF was observed following
consumption of a high flavanol (516 mg) cocoa drink compared with a low flavanol (39 mg) drink,
which peaked at 2 h and returned to baseline after approximately 6 h [98]. This study was only
carried out in four volunteers; however, a similar study also observed a significant increase in regional
perfusion at 2 h, particularly in the anterior cingulate cortex and central opercular cortex of the
parietal lobe, when given a flavanol-rich (494 mg) cocoa drink compared with a low flavanol (23 mg)
cocoa drink [102]. The increases in CBF with a peak reported at 2 h in these studies corresponds
with effects seen on FMD response in studies of vascular function [35]. With regards to longer
term supplementation, studies have indicated an increase in blood flow following consumption
of flavanol-rich (450 mg and 900 mg) cocoa drinks for 1–2 weeks in healthy older adults [103,104].
Beneficial effects on blood flow were also demonstrated over a three-month supplementation period
with 900 mg cocoa flavanols per day; dentate gyrus function was shown to be enhanced in healthy older
adults when compared with those following a low flavanol diet [105]. In contrast, dark (394 mg total
polyphenols) and milk (200 mg total polyphenols) chocolate consumption was found to significantly
lower CBF response during cognitive tasks with no implications for cognitive function when compared
with white chocolate [73]. Maintenance of cognitive ability would suggest that there may be other
mechanisms involved, allowing the brain to function more efficiently with reduced blood flow.
However, not all data supports the beneficial effects of cocoa flavonoids on CBF. A study looking into
the acute and sub-chronic effects of a cocoa supplement containing 250 mg of catechin polyphenols
found no significant changes in blood flow to the brain, perhaps due to the dosage administered being
too low to elicit any benefit or because of the method used, transcranial Doppler sonography, is not as
sensitive as others [40].
A number of studies have also been carried out with other flavonoid-rich foods, albeit with mixed
results. Blueberries have been found to increase regional perfusion, with an increase in CBF being
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observed in the precentral and middle frontal gyrus of the frontal lobe and the angular gyrus of the
parietal lobe following consumption of a flavonoid-rich (579 mg) blueberry beverage compared with
a control [99]. Further to this, a more recent study in healthy adults also found increases in regional
perfusion, specifically in the parietal and occipital lobes following 12 weeks of supplementation with a
blueberry concentrate containing 387 mg anthocyanins [106]. Increases in regional perfusion in the
interior and middle right frontal gyrus have also been observed 2 h post consumption of a citrus
drink containing 70.5 mg flavanones [100]. On the other hand, a reduction in CBF to the frontal cortex
in healthy adults was observed following a 135 mg dose of pure epigallocatechin gallate (EGCG),
the main catechin found in green tea, and no effect with a 270 mg dose when compared with the
control [107]. The authors suggest that EGCG may not have a straightforward dose response profile,
thus explaining the variation in results seen here arising from different dosages. In addition, it may be
that pure compounds do not always have the same effect as can be seen when ingested as a whole
food and there may be beneficial synergistic effects at play. It may also be that EGCG improves other
aspects of brain function, thus reducing the need for blood flow in the frontal cortex as discussed
previously with cocoa [73,107].
Whilst there is some conflicting evidence, it would seem that current research tends to demonstrate
improvements in regional perfusion, particularly with regard to acute flavonoid supplementation.
It may also be possible for flavonoids to optimise cerebrovascular function in certain regions, in
turn reducing CBF. Further research into this effect, the specific regions of the brain which are
affected and the effects of chronic consumption would be useful, along with more studies linking
the effects of flavonoids in the periphery with those in the brain as there is only one to date [73].
Additional research is essential in order to further our understanding of how flavonoids may be able
to exert neuroprotective effects and their potential to prevent the development of neurodegeneration.
See Table 3 for a summary of studies assessing the impact of flavonoids on cerebral blood flow.
6. Conclusions
Current research suggests that flavonoids are able to exhibit cardio and neuroprotective effects, as
demonstrated with improvements in FMD response, reductions in blood pressure and increases in CBF,
all effects which can be translated into reductions in the risk of disease. However, the changes observed
are not yet fully understood and there are currently discrepancies in the literature. This is largely due
to the heterogeneity of intervention studies in terms of the study design, population observed, and
duration of the intervention period. Future studies should investigate the dose and form of flavonoid
administered in order to elucidate the optimal dose and explore the potential synergistic effects of
whole foods as opposed to pure compounds. With regards to cerebrovascular health, research should
focus on the areas of the brain in which flavonoids seem to demonstrate the greatest effects in order
to have a better understanding of the mechanisms of action and how to target these areas in order
to achieve the optimum benefit. Further research in these areas would help us to understand the
beneficial effects that the incorporation of daily consumption of flavonoids are able to have on human
health, particularly with regard to potentially preventing CVD and neurodegenerative diseases such
as vascular dementia.
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Table 3. Summary of studies investigating the effect of flavonoids on cerebral blood flow.
Study Flavonoid Source and Dose Duration Sample Effects
Francis et al.
(2006) [98]
Cocoa
516 mg flavanols Acute
Healthy adults
(aged 24–31 years, n = 4) Increase in CBF across grey matter
Lamport et al.
(2015) [102]
Cocoa
494 mg flavanols Acute
Healthy older adults
(aged 50–65 years, n = 18)
Increase in regional perfusion (anterior
cingulate cortex, central opercular cortex)
Sorond et al.
(2008) [104]
Cocoa
450 mg flavanols 1 week
Healthy older adults
(aged 59–83 years, n = 21) Increase in cerebral blood flow velocity
Brickman et al.
(2014) [105]
Cocoa
900 mg flavanols 3 months
Healthy older adults
(aged 50–69 years, n = 41)
Increase in cerebral blood
volume in the dentate gyrus
Marsh et al.
(2017) [73]
Chocolate
395 mg (dark),
200 mg (milk) total polyphenols
Acute Postmenopausal women(n = 12)
Reduction in cerebral blood flow velocity
with both dark and milk chocolate
Massee et al.
(2015) [40]
Cocoa
250 mg catechin polyphenols
Acute and
4 weeks
Healthy younger adults
(aged 18–40 years, n = 40) No significant effect
Dodd et al.
(2012) [99]
Blueberry
579 mg flavonoids Acute
Healthy younger adults
(aged 18–25 years, n = 19)
Increase in regional perfusion
(occipital cortex, frontal lobe, angular gyrus)
Bowtell et al.
(2017) [106]
Blueberry
387 mg anthocyanins 12 weeks
Healthy older adults
(aged >65 year, n = 26)
Increase in regional perfusion
(parietal lobe, occipital lobe)
Lamport et al.
(2016) [100]
Citrus
70.5 mg flavanones Acute
Healthy young subjects
(aged 18–30 years, n = 24)
Increase in regional perfusion
(inferior and middle right frontal gyrus)
Wightman et al.
(2012) [107]
EGCG
135 mg, 270 mg Acute
Healthy adults
(aged 18–30 years, n = 27)
Reduction in CBF to frontal cortex
(135 mg), no effect of 270 mg
CBF: cerebral blood flow.
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